Solace - $130M Series C

REVOLUTIONIZING PATIENT ADVOCACY: Solace stands at the forefront of patient support, offering a vital service that pairs individuals with expert healthcare advocates. These professionals guide patients through the intricate landscapes of medical diagnoses, treatment plans, insurance claims, and administrative challenges, ensuring they receive optimal care and informed decision-making throughout their health journeys.

THE IMPACT OF $130M SERIES C FUNDING: The substantial $130 million Series C funding will be strategically deployed to scale Solace's advocate network, invest in advanced technological infrastructure, and accelerate product development. This capital infusion is crucial for enhancing the platform's capabilities, improving patient-advocate matching, and expanding service offerings to meet the growing demand for personalized healthcare support.

MARKET LEADERSHIP AND EXPANSION: With its base in Redwood City, California, Solace has established itself as a leader in the digital health advocacy sector. This funding round underscores investor confidence in Solace's business model and its potential for significant growth. Plans for expansion include broadening its geographic footprint across North America and forging new partnerships within the healthcare ecosystem to reach more patients in need.

A FUTURE OF EMPOWERED HEALTHCARE: Solace envisions a future where every patient feels empowered, informed, and supported, regardless of the complexity of their medical situation. By leveraging this new investment, Solace is poised to drive innovation in patient advocacy, reduce healthcare disparities, and fundamentally transform how individuals experience and navigate their health and wellness.